Kindred Biosciences, Inc.
(NASDAQ : KIN)

( )
KIN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -0.81%158.041.9%$234.39m
MYLMylan NV -1.11%14.213.2%$81.50m
TEVATeva Pharmaceutical Industries Ltd. -0.81%8.572.0%$70.20m
RDYDr. Reddy's Laboratories Ltd. -1.07%67.832.0%$11.90m
TXMDTherapeuticsMD, Inc. -3.68%1.3122.1%$3.21m
KINKindred Biosciences, Inc. -0.65%4.620.3%$2.05m
ABEOAbeona Therapeutics, Inc. 6.56%1.954.4%$1.89m
JAGXJaguar Health, Inc. -8.02%0.301.4%$1.65m
COCPCocrystal Pharma, Inc. -5.42%0.900.0%$1.57m
TAROTaro Pharmaceutical Industries Ltd. -1.08%54.906.5%$1.45m
LFVNLifeVantage Corp. -1.49%12.553.3%$0.90m
CPHIChina Pharma Holdings, Inc. -1.65%0.360.1%$0.10m

Company Profile

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.